Key Market Indicators
Hungarian pharmaceutical research and development expenditure is projected to soar to $3 billion by 2028, up from the current $1.6 billion in 2023. This growth represents an average annual increase of nearly 10%. Since 2010, Hungary's supply in this sector has surged by an impressive 23% year over year. In 2023, Hungary secured the fifth spot in the global ranking for pharmaceutical R&D spending. South Korea led the pack with an expenditure of $1.6 billion, slightly ahead of Hungary. China, Germany, and South Korea occupied the second, third, and fourth positions, respectively, in this ranking.
